A detailed history of Ra Capital Management, L.P. transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Ra Capital Management, L.P. holds 3,517,259 shares of ITOS stock, worth $31 Million. This represents 0.79% of its overall portfolio holdings.

Number of Shares
3,517,259
Holding current value
$31 Million
% of portfolio
0.79%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$10.33 - $18.09 $36.3 Million - $63.6 Million
3,517,259 New
3,517,259 $52.2 Million
Q4 2023

Feb 14, 2024

BUY
$8.57 - $11.06 $37.9 Million - $48.9 Million
4,417,259 New
4,417,259 $48.4 Million
Q2 2021

Aug 16, 2021

BUY
$17.9 - $36.1 $17 - $36
1 Added 0.0%
4,417,259 $113 Million
Q3 2020

Nov 16, 2020

BUY
$17.57 - $32.92 $77.6 Million - $145 Million
4,417,258 New
4,417,258 $109 Million

Others Institutions Holding ITOS

About iTeos Therapeutics, Inc.


  • Ticker ITOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,575,300
  • Market Cap $313M
  • Description
  • Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...
More about ITOS
Track This Portfolio

Track Ra Capital Management, L.P. Portfolio

Follow Ra Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Ra Capital Management, L.P. with notifications on news.